Search Results - "Dingmann, C"

A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's disease by Shoulson, I, Penney, J, McDermott, M, Schwid, S, Kayson, E, Chase, T, Fahn, S, Greenamyre, J T, Lang, A, Siderowf, A, Pearson, N, Harrison, M, Rost, E, Colcher, A, Lloyd, M, Matthews, M, Pahwa, R, McGuire, D, Lew, M F, Schuman, S, Marek, K, Broshjeit, S, Factor, S, Brown, D, Feigin, A, Mazurkiewicz, J, Ford, B, Jennings, D, Dilllon, S, Comella, C, Blasucci, L, Janko, K, Shulman, L, Wiener, W, Bateman-Rodriguez, D, Carrion, A, Suchowersky, O, Lafontaine, A L, Pantella, C, Siemers, E, Belden, J, Davies, R, Lannon, M, Grimes, D, Gray, P, Martin, W, Kennedy, L, Adler, C, Newman, S, Hammerstad, J, Stone, C, Lewitt, P, Bardram, K, Mistura, K, Miyasaki, J, Johnston, L, Cha, J H, Tennis, M, Panniset, M, Hall, J, Tetrud, J, Friedlander, J, Hauser, R, Gauger, L, Rodnitzky, R, Deleo, A, Dobson, J, Seeberger, L, Dingmann, C, Tarsy, D, Ryan, P, Elmer, L, Ruzicka, D, Stacy, M, Brewer, M, Locke, B, Baker, D, Casaceli, C, Day, D, Florack, M, Hodgeman, K, Laroia, N, Nobel, R, Orme, C, Rexo, L, Rothenburgh, K, Sulimowicz, K, Watts, A, Wratni, E, Tariot, P, Cox, C, Leventhal, C, Alderfer, V, Craun, A M, Frey, J, McCree, L, McDermott, J, Cooper, J, Holdich, T, Read, B

“…Preclinical studies suggest that glutamate antagonists help ameliorate motor fluctuations in patients with PD treated with levodopa. In a multicenter,…”
Get full text

Risk of impaired coagulation in warfarin patients ascending to altitude (>2400 m) by Van Patot, Martha C Tissot, Hill, Ashley E, Dingmann, Colleen, Gaul, Lawrence, Fralick, Kelly, Christians, Uwe, Honigman, Benjamin, Salman, M D

“…Approximately 476,000 people on warfarin therapy visit a resort at altitude (>2400 m) annually in Colorado. Clinicians practicing at altitude have expressed…”
Get more information

R1514Q substitution in Lrrk2 is not a pathogenic Parkinson's disease mutation by Nichols, William C., Marek, Diane K., Pauciulo, Michael W., Pankratz, Nathan, Halter, Cheryl A., Rudolph, Alice, Shults, Clifford W., Wojcieszek, Joanne, Foroud, Tatiana

“…Mutations in LRRK2 were first reported as causing Parkinson's disease (PD) in late 2004. Since then, approximately a dozen LRRK2 substitutions have been…”
Get full text

A multicenter randomized controlled trial of remacemide hydrochloride as monotherapy for PD

Get full text